Hainan Huluwa Pharmaceutical Group Co., Ltd.
SSE:605199.SS
9.59 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -269.517 | 106.498 | 84.742 | 69.556 | 121.502 | 120.329 | 100.539 | 22.128 | 33.763 |
| Depreciation & Amortization
| 77.821 | 59.715 | 51.029 | 48.165 | 43.512 | 41.505 | 35.506 | 28.617 | 28.422 |
| Deferred Income Tax
| 0 | 0 | 3.022 | 6.953 | -13.606 | -0.56 | -0.293 | 0.045 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.72 | 0 |
| Change In Working Capital
| 4.73 | -191.461 | 78.809 | -35.616 | -182.823 | -34.752 | -114.553 | -36.841 | -12.611 |
| Accounts Receivables
| 17.803 | -205.084 | -245.052 | -34.155 | -197.453 | -45.723 | -112.749 | -83.832 | -14.265 |
| Inventory
| -173.063 | -59.961 | -6.061 | -28.793 | -35.838 | 16.702 | -57.84 | -35.862 | -10.517 |
| Accounts Payables
| 0 | 73.584 | 326.9 | 20.379 | 64.075 | -5.171 | 56.33 | 82.808 | 0 |
| Other Working Capital
| 159.99 | -0 | 3.022 | 6.953 | -13.606 | -0.56 | -56.713 | -0.979 | -2.094 |
| Other Non Cash Items
| 37.851 | 53.501 | 24.132 | 20.379 | 21.109 | 17.43 | 10.305 | 76.058 | 15.391 |
| Operating Cash Flow
| -149.116 | 28.252 | 238.711 | 102.484 | 3.3 | 144.513 | 31.797 | 89.963 | 64.965 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -156.231 | -489.2 | -392.322 | -137.624 | -59.415 | -58.395 | -72.816 | -157.578 | -40.988 |
| Acquisitions Net
| 13.676 | -35.096 | 0.264 | 0.111 | 0.077 | 58.402 | 0.073 | -0.161 | 0.028 |
| Purchases Of Investments
| 0 | 0 | -210 | -14 | -209 | -250 | -115.145 | -299 | -108.5 |
| Sales Maturities Of Investments
| 0 | 0 | 190.459 | 14.112 | 210.723 | 253.057 | 117.666 | 299.657 | 108.641 |
| Other Investing Activites
| 0.073 | 0.085 | 0 | 20.304 | -20 | -58.395 | 0.79 | 29.987 | -22.589 |
| Investing Cash Flow
| -142.482 | -524.211 | -411.6 | -117.098 | -77.616 | -55.332 | -69.432 | -127.094 | -63.408 |
| Financing Activities: | |||||||||
| Debt Repayment
| -11.12 | 594.852 | 178.5 | 203.684 | 118.533 | -28.911 | -11.859 | -121.467 | 62.733 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | -3.982 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 3.982 | 0 | 0 | 0 |
| Dividends Paid
| -92.159 | -31.563 | -14.351 | -60.016 | -7.996 | -81.002 | -80.559 | -13.463 | -15.301 |
| Other Financing Activities
| 125.105 | -10.233 | 0 | 16.38 | 150.567 | -3.581 | 225.864 | 195.677 | -11.65 |
| Financing Cash Flow
| 21.825 | 553.055 | 164.15 | 146.316 | 261.104 | -113.493 | 133.445 | 60.748 | 35.782 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Net Change In Cash
| -269.772 | 57.096 | -8.738 | 131.702 | 186.788 | -24.312 | 95.81 | 23.616 | 37.339 |
| Cash At End Of Period
| 251.166 | 520.938 | 463.841 | 472.58 | 340.877 | 154.089 | 178.402 | 82.592 | 58.975 |